Language
English
Publication Date
12-30-2024
Journal
Journal of the Pediatric Infectious Diseases Society
DOI
10.1093/jpids/piae116
PMID
39513400
PMCID
PMC12476979
PubMedCentral® Posted Date
11-8-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Of 319 children with invasive candidiasis, 67 (21%) transitioned from intravenous to enteral antifungal therapy. Eight (12%) transitioned back to intravenous antifungal therapy, one due to perceived treatment failure defined by clinical progression or worsening. Global treatment response at study completion was successful in 66 participants who transitioned to enteral therapy.
Keywords
Humans, Antifungal Agents, Candidiasis, Invasive, Child, Female, Male, Child, Preschool, Adolescent, Infant, Administration, Intravenous, Triazoles, Cohort Studies, Treatment Outcome
Published Open-Access
yes
Recommended Citation
Bucayu, Robert F T; Boge, Craig L K; Yildirim, Inci; et al., "Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network" (2024). Faculty, Staff and Students Publications. 5973.
https://digitalcommons.library.tmc.edu/baylor_docs/5973